Search

You searched for "Optics"

1899 results found

Emerging developments in dry eye

1 August 2017 | | EYE - Cornea
An estimated 344 million people worldwide suffer from dry eye [1]. This chronic syndrome is characterised by a vicious cycle of tear film hyperosmolarity, tear instability and corneal stress, leading to increased friction, inflammation, ocular surface damage and decreased visual...

Improved efficacy expected with second-generation microinvasive glaucoma surgery (MIGS) devices

1 July 2015 | | EYE - Glaucoma
Microinvasive surgical approaches to primary open-angle glaucoma (POAG) offer minimally traumatic options for effective intraocular pressure (IOP) reduction in appropriately selected glaucoma patients. Increases in laser trabeculoplasty rates and wider adoption of glaucoma drainage device filtration procedures, together with the...

Ciliatech appoints world-class panel of eyecare specialists to newly created KOL advisory board

6 December 2024 | research, education, KOL, glaucoma, innovation, treatment
Ciliatech will leverage ophthalmic expertise of seven-member advisory board to bring to market Intercil® Uveal Spacer, a novel glaucoma implant offering unique benefits to eye surgeons and patients across the globe Ciliatech, an innovative medtech company focusing on the treatment...

Quiz Jun/Jul 2024

3 June 2024 | | EYE - Oncology, EYE - Paediatrics, EYE - Strabismus, EYE - Pathology, EYE - General
History A one-year-old girl originally presented with a red eye, initially bilaterally and later in the left only. On examination a membrane was found on the tarsal conjunctiva of the upper eyelid (Figure 1). Figure 1: Anterior segment. Serum plasminogen...

Triamcinolone (TA) deposits following subcutaneous injection to treat chalazion

2 August 2022 | | EYE - Oculoplastic, EYE - General
Chalazia are chronic lipogranulomatous inflammations of the eyelid secondary to a blocked meibomian gland. Whilst most resolve spontaneously, certain chalazia warrant treatment. Options include incision and curettage (I&C), lesion excision, intralesional steroid injections, and botox injections [1]. I&C is usually...

COVID-19 and Ophthalmology: RCOphth, ICEH and COECSA joint webinar

13 August 2020 | | EYE - General
The Royal College of Ophthalmology of Eastern, Central and Southern Africa (COECSA) and the Royal College of Ophthalmologists (the Royal College) have had a successful VISION 2020 LINK partnership for over 12 years. The partnership was established by the VISION...

Embedding EMR for a complete transformation in user experience

1 August 2016 | | EYE - General
Informatics and IT projects in the NHS have a history of being over budget, delivered late and not fulfilling the design brief. “But it doesn’t have to be that way,” believes Chris Canning, Consultant Ophthalmologist and Chief Clinical Information Officer...

What’s new in wet AMD papers?

1 December 2016 | | EYE - Vitreo-Retinal
Paper presentations on neovascular (‘wet’) age-related macular degeneration (AMD) from the 16th European Society of Retina Specialists Congress, Copenhagen, September 2016, outline recent research directions evaluating the impact of vision loss on key health domains, patient preferences in the process...

OrCam Technologies launches new class of AI reading device

11 August 2023 | AI, artificial intelligence, Reading, Technology, OrCam, OrCam Read 3
OrCam Technologies, innovator of life-changing, personal 'AI as a companion' solutions, has announced the UK launch of the OrCam Read 3, an all-in-one solution for people with vision loss or reading fatigue, or who find reading challenging.

NHS staffing experts back insourcing as practical solution to long NHS waiting lists

30 October 2023 | insourcing, outsourcing, NHS, waiting list, Claire Dubowski, 18 Week Support
NHS staffing experts back insourcing as practical solution to long NHS waiting lists amid cross-party consensus on the need for increased independent sector support.

Cricket fan Tony credits NHS cataract surgery with improving his mental health as well as his sight

15 November 2023 | SpaMedica, Cataract surgery, NHS
Tony, 65, could see the ball at Trent Bridge match ‘for the first time in years’ and says ‘everything’ in life has improved, after cataract removal at SpaMedica.

Andy Hill (NuVision Biotherapies) discusses recent AOP update to clinical guidelines

8 December 2023 | NuVision, Andy Hill, amniotic membranes, guidelines, AOP, optometrist, outpatient, dry eye, lens
There are currently 600,000 people on the NHS waiting list for ophthalmology treatment, and over 5 million people in the UK currently live with dry eye disease. Here Andy Hill, CEO at NuVision Biotherapies Ltd, discusses a recent update to clinical guidelines and what this means for optometrists, patients, and taxpayers.